Article metrics
PDF
Other content recommended for you
- Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?
- Intellectual property waiver for covid-19 vaccines will advance global health equity
- Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- COVID-19 vaccines pricing policy options for low-income and middle- income countries
- The COVID-19 vaccine patent: a right without rationale
- Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider’s story
- Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity
- Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers